Long-term survival and hemodynamics after endothelin-A receptor antagonism and angiotensin-converting enzyme inhibition in rats with chronic heart failure: Monotherapy versus combination therapy

Circulation

Volumn 106, Issue 9, 2002, Pages 1159-1164

  Mulder, Paul ^a   Boujedaini, Houssaine ^a   Richard, Vincent ^a   Henry, Jean Paul ^a   Renet, Sylvanie ^a   Münter, Klaus ^a   Thuillez, Christian ^a  

^a INSERM   (France)

Author keywords

Endothelin; Heart failure; Hemodynamics; Inhibitors, angiotensin converting enzyme

Indexed keywords

COLLAGEN; DARUSENTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN A RECEPTOR ANTAGONIST; TRANDOLAPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG MIXTURE; ECHOCARDIOGRAPHY; HEART FAILURE; HEART LEFT VENTRICLE PRESSURE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMICS; MALE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CHRONIC DISEASE; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; LIGATION; MALE; MYOCARDIUM; PEPTIDYL-DIPEPTIDASE A; PHENYLPROPIONATES; PYRIMIDINES; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; STROKE VOLUME; SURVIVAL RATE; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING; WAKEFULNESS;

EID: 0037183553     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000027138.07524.38     Document Type: Article

References (32)

1. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure
2. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction
3. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure: Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan)
4. Acute hemodynamic and neurohumoral effects of selective ET(A) receptor blockade in patients with congestive heart failure: ET 003 Investigators
5. Comparison of the acute effects of a selective endothelin ETA and a mixed ETA/ETB receptor antagonist in heart failure
6. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure
7. Long-term endothelin receptor antagonist administration improves alterations in expression of various cardiac genes in failing myocardium of rats with heart failure
8. Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure
9. Role of endogenous endothelin in chronic heart failure: Effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling
10. Role of endothelin in deterioration of heart failure due to cardiomyopathy in hamsters: Increase in endothelin-1 production in the heart and beneficial effect of endothelin-A receptor antagonist on survival and cardiac function
11. Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat
12. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
13. Long-term survival in severe heart failure in patients treated with enalapril: Ten year follow-up of CONSENSUS I
14. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial
15. Hemodynamic effects of bosentan in patients with chronic heart failure
16. Survival after an experimental myocardial infarction: Beneficial effects of long-term therapy with captopril
17. Influence of chronic captopril therapy on the infarcted left ventricle of the rat
18. Long-term effects of nonselective endothelin A and B receptor antagonism in postinfarction rat: Importance of timing
19. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat
20. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
21. Peripheral artery structure and endothelial function in heart failure: Effect of ACE inhibition
22. Survival after myocardial infarction in the rat: Role of tissue angiotensin-converting enzyme inhibition
23. Selective endothelin-A versus combined endothelin-A/endothelin-B receptor blockade in rat chronic heart failure
24. Endothelin antagonism in experimental ischemic heart failure: Hemodynamic, structural and neurohumoral effects
25. Early versus delayed angiotensin-converting enzyme inhibition in experimental chronic heart failure: Effects on survival, hemodynamics, and cardiovascular remodeling
26. Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival after myocardial infarction in rats
27. Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure
28. Survival after myocardial infarction in rats: Captopril versus losartan
29. Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: Possible involvement of myocardial endothelin system in ventricular remodeling
30. Biphasic survival response to amlodipine after myocardial infarction in rats: Association with cardiac vascular remodeling
31. M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study)
32. Angiotensin converting enzyme inhibition modulates endogenous endothelin in chronic canine thoracic inferior vena caval constriction